Health Care & Life Sciences » Biotechnology | Oncobiologics Inc.

Oncobiologics Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2014
2015
2016
2017
Sales/Revenue
9,050.50
5,219.20
2,979.60
3,811.50
SG&A Expense
20,564.50
49,957.30
51,932.50
36,999.70
EBIT
12,392.40
46,562.60
-
35,880.30
Unusual Expense
-
-
-
3,158.50
Interest Expense
901.10
2,297.30
1,851.80
5,625.80
Pretax Income
13,293.50
48,860.00
53,199.00
38,347.60
Income Tax
439.00
190.10
103.00
501.50
Consolidated Net Income
13,732.50
48,669.90
53,302.00
40,025.90
Net Income
13,732.50
47,393.30
53,302.00
40,025.90
Net Income After Extraordinaries
13,732.50
47,393.30
53,302.00
40,025.90
Net Income Available to Common
20,658.30
52,998.40
63,139.00
40,025.90
EPS (Basic)
0.99
2.54
3.67
1.80
Basic Shares Outstanding
20,901.20
20,901.20
17,213.00
24,022.40
EPS (Diluted)
0.99
2.54
3.67
1.80
Diluted Shares Outstanding
20,901.20
20,901.20
17,213.00
24,041.80
EBITDA
11,513.90
44,738.00
48,952.90
33,188.20
Minority Interest Expense
-
1,276.60
-
-
Other After Tax Income (Expense)
-
-
-
1,176.70
Preferred Dividends
6,925.90
5,605.10
9,837.00
-

About Oncobiologics

View Profile
Address
7 Clarke Drive
Cranbury New Jersey 08512
United States
Employees -
Website http://www.oncobiologics.com
Updated 09/14/2018
Oncobiologics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.